Navigation Links
FDA Gives Green Signal To Sanofi-Aventis SA's Cancer Drug Taxotere

French drug maker Sanofi-Aventis SA announced on Thursday that the US Food and Drug Administration has approved its cancer drug Taxotere to treat patients with stomach cancer.// This approval means that Taxotere can be used in combination with chemotherapy drugs cisplatin and 5-fluorouracil to treat stomach cancers that have not been treated with chemotherapy.

Taxotere is also approved to treat some types of breast cancer and lung cancer. Certain types of prostate cancer can also be treated with the drug when used in combination with prednisolone. Sanofi-Aventis SA was able to speed up the review process after data from a late-stage clinical trial showed that the survival period increased when taxotere was used. Advanced or spreading stomach cancer does not have a big survival period.
'"/>




Page: 1

Related medicine news :

1. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
2. Gene Therapy Gives Hope For Patients With Muscular Dystrophy
3. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
4. US Doctors Association Gives away $110,000 To NGO’
5. Woman In Coma Gives Birth To Daughter
6. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant
7. New Eye Surgery Gives Hope To Short-Sighted
8. Jharkhand Gives Health industry status
9. WHO Gives Its Approval For Bird Flu Test Kit
10. FDA Gives Its Approval For Inhaler
11. Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No

Post Your Comments:
(Date:11/27/2009)... Three new interactive anatomy education apps from...pand health sciences learning opportunities for iP...ham, NC (Vocus) November 27, 2009 -- Modality, In... division of Wolters Kluwer Health, today announce...apps on the App Store. Clemente’s Anatomy, R...
(Date:11/26/2009)... drug tetrathiomolybdate (TM) has been shown in st...isease, a disease caused by an overload of copper,...n. Very little, however, is known about how the dr...ed by Northwestern University researchers now has ... structure of TM bound to copper-loaded metallocha...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, a pr...s one of a growing number of physicians who are t... to connect with individuals who are interested in...esity. Dr. Kim is utilizing Facebook to share befo...tice with the community. , ...
(Date:11/25/2009)...5/PRNewswire-USNewswire/--Whenmostpeopleheartheacr...nalsogivepatientsthehelptheyneed.TMJstandsfortheTe...e)contacts/connectswithyourskull(temporalbone). ,...ionarepainwithchewing,clickingorpoppingofthejaw.Bu...luding:headaches,fatigue,sleepdisturbances,irritab...
(Date:11/25/2009)...Newswire/-SentinelleMedicalInc.,aleadingmanufactur...launchesasuiteofnewleadingedgeclinicalapplications...year,sRadiologicalSocietyofNorthAmerica(RSNA)annua...A).Theapplicationsleveragetheuniquehighqualityimag...sandsupportmultipleimagingmodalitiesformulti-param...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...erium that causes the potentially dangerous sexual...d pave the way for a preventive vaccine and better...once caused widespread epidemics and is still a ma...jections of penicillin or other antibiotics. ...
...rder to prevent problems realted to the teeth. Kid...fier after the age of 2 may be more likely to end ... reach adolescence, a team of dentists reports. T...h and an irregular bite, compared with their peers...
...ndard emergency department migraine therapy with m...ce the effectiveness of treatment.// Dr. Jill Corb... of Medicine in the Bronx, New York, note that the... have shown that magnesium sulfate infusions are w...
... oral cancer at its earliest stages. Cytobrush bio...s at the University of Philadelphia//School of Den...vance over previous cytology (PAP smear-type) test...l cancer. The survival rate for this prevalent can...
...er contaminated with chemical byproducts from chlo...ing water.// When it is added to water that contai...ns, however, it can form compounds such as chlorof...have increased health risks including miscarriage,...
...they have found a way to use blood stem cells to m...ing an obstacle to certain forms of gene therapy. ...om improving the body's immune response to develop...to any of the various types of cells in the blood,...
Other Medicine News:Health News:A new study surpasses Gene Therapy Hurdle 2
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, UnitedStatesDentalDevices...w.reportlinker.com/p0158733/United-States-Dental-D... ,, UnitedStatesDentalDevicesMarketAnalysisandF...nessentialsourceforin-depthinformationanddatarelat...
(Date:11/25/2009)... ,, WALTHAM,Mass.,Nov.25/PRNewswire/--Accord...tyonmedicaltechnologymarketintelligence,thenearly$...uetoseerapidgrowthoverthenextfiveyearsdespitethere...es 2010 reportfindsthatthismarketwillremainhighly...cingspecializeddevicesinpreviouslyunderservedsegme...
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, IntranasalDrugDelivery-US....com/p0164267/Intranasal-Drug-Delivery---US-Market...eliverymarketiswitnessinganexpansionoftherapeutica...peuticdrugstothedeliveryofsystemictherapeuticdrugs...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ANAVEX completes scale up manufacturing of ANAVEX 2 73 for Phase I Alzheimers disease clinical trials 5022 1ANAVEX completes scale up manufacturing of ANAVEX 2 73 for Phase I Alzheimers disease clinical trials 5022 2ANAVEX completes scale up manufacturing of ANAVEX 2 73 for Phase I Alzheimers disease clinical trials 5022 3Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 1Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 2Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 3Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 14176 4Los Angeles DUI Attorney Claims Diabetics Often Falsely Convicted of Drunk Driving 57756 1Los Angeles DUI Attorney Claims Diabetics Often Falsely Convicted of Drunk Driving 57756 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: